originally published Tuesday, April 04, 2023

Printable Version

All Biotech & Medical Stocks

This is a REALLY BIG STORY. Many years ago Resverlogix developed a product that purportedly has the ability to reset damaged DNA back to its original state and if this is true then this product holds out hope for the billions of people who have been damaged by the New World Order’s bioweapon attacks via Covid and the “vaccines” and other nasty bioweapons that they have created and may yet deploy, in their crazed ambition to reduce the world’s population by 90% or so. So, assuming that this product is not blocked somehow by the NWO, the profit potential for the company is gigantic.

I learned of this company and its product by reading an insightful article by Mr Bob Moriarty of 321gold and after first checking that the charts looked good, which they certainly do, I immediately mobilized to bring it to the attention of subscribers, sending out an email alert before today’s open, and today it has blasted higher on huge volume.

Turning now to the charts we see on its 5-year chart that Resverlogix suffered a particularly brutal bearmarket from its mid-2021 highs, losing over 98% of its value from high to low and as of yesterday it was still not far off its lows hit in December. This huge drop in price was in large part due to the BioTech sector falling out of favor and getting pummeled. By late 2021 into early 2022 it had looked like it was basing with its 2019 and 2020 lows and it is understandable that some investors may have bought it then on that basis, although we were not involved with it. However, it went on to breach the support at these lows and to plumb new depths.

On the 1-year chart we can see that immediately after breaking down to new lows it began a base building process and proceeded to mark out a Head-and-Shoulders bottom from last October that only showed signs of being complete today with the dramatic breakout move, although we should note that technically that it will not have broken out of the base until it gets above the February intraday highs at about 25 cents although that said a break above this level is pretty much a foregone conclusion given the enormous volume driving today’s move higher and the fact that it opened with a gap, which is bullish. Today’s action is a sign that this is heading much higher.

Today’s action suggests that Resverlogix will “not look back” from here and it is still rated a strong buy at the current price, especially as it has backed off from its intraday highs. Although trading has been very thin on the US OTC market in the recent past, we can expect that to improve as the bullmarket unfolds and volume was comparatively strong today on this market which bodes well.

Resverlogix Corp. website

Resverlogix Corp., RVX.CSX, RVXCF on OTC, trading at C$0.22, $0.155 at 1.45 pm EDT on 4th April 23.

Posted at 2.50 pm EDT on 4th April 23.

The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment or securities advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market technical analyst, Clive Maund is not a Registered Investment Advisor or Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks cannot be construed as a recommendation or solicitation to buy and sell securities.